Experimental group:Shenqi compound

3 trials

Sponsors

Teaching Hospital of Chengdu University of Traditional Chinese Medicine, Hospital of Chengdu University of Traditional Chinese Medicine

Conditions

Type 2 diabetestype 2 diabetes with lower extremity atherosclerosis

Early Phase 1

Traditional Chinese medicine Shenqi Compound to improve lower extremity atherosclerosis of patients with type 2 diabetes by affecting blood glucose fluctuation: study protocol for a randomized controlled multicenter trial

RecruitingChiCTR1900027693

Teaching Hospital of Chengdu University of Traditional Chinese Medicinetype 2 diabetes with lower extremity atherosclerosis

Start: 2019-11-14Updated: 2020-01-13

Traditional Chinese medicine Shenqi Compound to improve lower extremity atherosclerosis of patients with type 2 diabetes by affecting blood glucose fluctuation: study protocol for a randomized controlled multicenter trial

RecruitingITMCTR1900025355

Teaching Hospital of Chengdu University of Traditional Chinese Medicinetype 2 diabetes with lower extremity atherosclerosis

Start: 2019-11-14Updated: 2023-02-20

Evidence-based Evaluation of the Efficacy and Safety of Shenqi Compound for Early Intervention in Patients with High Cardiovascular Risk of Type 2 Diabetes Mellitus

Active, not recruitingChiCTR2300069219

Hospital of Chengdu University of Traditional Chinese MedicineType 2 diabetes

Start: 2023-03-10Updated: 2023-05-29

Related Papers

Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial

Frontiers in Cardiovascular Medicine2024-01-081 citations